TerrAscend Expands Footprint in New Jersey with Acquisition of Aunt Mary's Dispensary Canadian‑listed cannabis operator TerrAscend Corp. announced the closing of its acquisition of Aunt Mary's Dispensary LLC in Hunterdon County, New Jersey. The deal adds a high‑performing retail location that is expected to be accretive to earnings, and brings the company's total U.S. dispensary count to 21 across five states and Canada. The transaction includes a convertible debenture and cash consideration and is compliant with New Jersey's favorable regulatory regime for diversely owned businesses. TerrAscend Corp., a publicly listed cannabis company focused on cultivation, manufacturing and retail operations in the United States and Canada, today confirmed the completion of its transaction with Aunt Mary's Dispensary LLC located in Hunterdon County, New Jersey. The acquisition represents the company's fifth retail storefront in New Jersey and is expected to add more than US$10 million in annualized revenue and immediate positive impact to EBITDA and free cash flow. TerrAscend will fully consolidate the new dispensary once certain conditions are met, and the new location will become part of the company's flagship brand portfolio, which includes The Apothecarium, Cookies, Kind Tree, Legend, State Flower, Wana, Cuue, One and Valhalla.The deal was structured on terms announced in June 2026. The total consideration of US$9 million was split into a five‑year unsecured convertible debenture that carries a 6.0 % interest rate and gives TerrAscend the option to purchase 35 % of Aunt Mary's, and a cash payment of US$6 million payable upon exercise of that option. The transaction complies with New Jersey's regulatory framework that encourages investments in businesses owned by under‑represented groups.Once the option is exercised and all integration and regulatory approvals are completed, the company will report the new dispensary on its consolidated financial statements and grow its U.S. retail presence to 21 sites across New York, New Jersey, Pennsylvania, Maryland, Ohio, California and Canada. Executive Chairman Jason Wild shared his excitement: "Aunt Mary's generates more than US$10 million in annualized revenue today, and we see meaningful opportunities to enhance sales and profitability through integration of our premium brand portfolio," he said."We are excited to welcome the Aunt Mary's team to the TerrAscend family. " TerrAscend operates a mix of retail locations and cultivation, processing and manufacturing facilities in its principal markets including Pennsylvania, New Jersey, Maryland, Ohio and California through its subsidiary TerrAscend Growth Corp. The company places a strong emphasis on consistent quality and supply chain efficiency, which has enabled it to deliver a wide range of products to both the medical and adult‑use segments.The company also highlighted recent regulatory developments that impact its U.S. operations. On April 23, 2026, the U.S. Department of Justice issued a final rule moving marijuana used in FDA‑approved drug products and marijuana with a state medical license from Schedule I to Schedule III of the Controlled Substances Act. This change applies only to specific, licensed products, and all other cannabis remains a Schedule I controlled substance.Financial transactions that involve proceeds from cannabis activities can still trigger federal investigations under anti‑money‑laundering laws. While federal enforcement tends to be lax toward compliant state‑licensed operators, the company remains exposed to potential legal risk and must continue to comply with both state and federal laws. TerrAscend's management repeated that the acquisition is accretive to earnings before interest, taxes, depreciation and amortization (EBITDA) and free cash flow.The company also emphasized its strategy of expanding both retail and wholesale capabilities across North America as part of its long‑term growth plan. For further information about TerrAscend and its operations, visitors can consult the company's website at www.terrascend.com. The company's forward‑looking statements contained in this release are subject to risks and uncertainties that could cause actual results to differ materially from those expressed herein